Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Brand drugFirst approved 2001

Focalin(Dexmethylphenidate Hcl)

Medicare prescription drug cost, prescriptions and prescribers, 2024

$103K

Medicare cost, 2024

Medicare drug plans spent $102,551 on Focalin (dexmethylphenidate hcl) in 2024, for 996 prescriptions and refills filled by 225 patients. California accounts for the most spending ($14,538, 14% of the total).

Medicare cost, 2024

$103K

+9.9% from 2023

Prescriptions

996

$102.96 per claim

Patients

225

281 prescribers

Total spending, 2024

$102K

$455.47 per patient

Questions and answers

How much does Medicare spend on Focalin?

Medicare prescription drug plans paid $103K for Focalin in 2024, for 996 prescriptions and refills to 225 patients (up 9.9% from 2023). The average cost per claim was $102.96.

Which state spends the most on Focalin?

California had the highest Medicare cost for Focalin in 2024: $15K for 107 claims, followed by Wisconsin ($8,967).

Who prescribes Focalin the most?

Alfred W Forrester, psychiatry & neurology in Timonium, MD, had the highest Medicare cost for Focalin in 2024: 12 claims costing $4,803.

Spending over the years

Medicare spending by year

All plans and makers

Prescriber data: cost by year

Medicare spending on Focalin was $102K in 2024, the highest year shown.

By state

Where the prescribers practice, 2024

Medicare cost by state

States with the highest cost

Top prescribers of Focalin, 2024

By Medicare drug cost

PrescriberTypeClaimsPatientsCost
Alfred W Forrester Timonium, MDPsychiatry & Neurology12Under 11$4,803
Meera Joseph Palm Beach Gardens, FLPsychiatry & Neurology12Under 11$3,094
Joseph Bergs Racine, WIPsychiatry12Under 11$2,895
Marshall J Bales Winnebago, WIPsychiatry13Under 11$2,285
Donald R Quinn Bristol, TNInternal Medicine13Under 11$1,912
Naeem A Qureshi Marion, ILPsychiatry11Under 11$1,869
Rafael D Guerrero Katy, TXPsychiatry & Neurology27Under 11$1,858
Jane Perr Roslyn Heights, NYPsychiatry12Under 11$1,619
Janet Gillis-Toffolo New Haven, CTNurse Practitioner28Under 11$1,587
Sherman W Cole Leawood, KSPsychiatry13Under 11$1,540
William Cipriano Westlake Vlg, CAPsychiatry14Under 11$1,184
Lawrence A May Tarzana, CAInternal Medicine12Under 11$981
Roxana G Llovet Bridgeport, CTPsychiatry12Under 11$973
David M Bear Pensacola, FLNeurology12Under 11$963
Gustavo J Cuadra Clearwater, FLPsychiatry12Under 11$956
Jason C Miller San Antonio, TXPsychiatry12Under 11$936
Amanda L Craven Moosic, PANurse Practitioner11Under 11$903
Jennifer L Taylor Hebron, CTNurse Practitioner11Under 11$886
Carol B Perez Fairfax, VAPsychiatry11Under 11$834
Jennifer S Lahmann La Crosse, WIPsychiatry12Under 11$576

Prescriber data by year

YearPrescribersClaimsPatientsCost
202212465296$82K
2023230829183$93K
2024281996225$103K

Makers, 2024

Spending by manufacturer as listed in the spending data

ManufacturerClaimsSpending
Novartis/Sandoz905$91K
SandozSDZ.SW logoSDZ.SW90$12K

Medicaid spending by quarter

Amount reimbursed by state Medicaid programs, all states

Amount reimbursed

Codes

National drug codes (packages)
3
RxNorm concept IDs
899518, 899519, 899548, 899549, 899557
Application numbers
NDA021278

More drugs: Medicare drug spending and the Prescriptions view.

Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.

LinkedInLinkedInXXYouTubeYouTube